APA (7th ed.) Citation

Pilipenko, P. I., Ivanova, A. A., Kotsiubinskaya, Y. V., Grigoryeva, V. N., Khrulev, A. Y., Skorokhodov, A. V., . . . Feigin, V. L. (2025). A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Pilipenko, Pavel I., et al. A Double-blind, Placebo-controlled, Randomized, Multi-centre, Phase III Study of MLC901 (NeuroAiDTMII) for the Treatment of Cognitive Impairment After Mild Traumatic Brain Injury. Public Library of Science (PLoS), 2025.

MLA (9th ed.) Citation

Pilipenko, Pavel I., et al. A Double-blind, Placebo-controlled, Randomized, Multi-centre, Phase III Study of MLC901 (NeuroAiDTMII) for the Treatment of Cognitive Impairment After Mild Traumatic Brain Injury. Public Library of Science (PLoS), 2025.